NCCN Task Force Report: PET/CT Imaging CME

Donald A. Podoloff, MD Author Information and Disclosures

Release Date: March 28, 2008; Valid for credit through March 28, 2009

Credits Available
Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™ for physicians

This program is based on a presentation from the NCCN 12th Annual Conference: Clinical Practice Guidelines & Quality Cancer CareTM held in Hollywood, Florida, on March 17, 2007. This activity is designed to be completed within approximately 45 minutes.

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the educational content; (3) take the post-test and complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 National Comprehensive Cancer Network.
G.E. Healthcare
Learning Objectives
Following this activity, participants should be able to:
  • Recognize novel PET/CT imaging endpoints;
  • Demonstrate the usefulness of new imaging techniques in managing solid tumors and lymphomas.
Author Disclosures
Donald A. Podoloff, MD
James E. Anderson Distinguished Professor in Nuclear Medicine; Radiology Division Head, Division of Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

Disclosure: Dr. Podoloff has disclosed that he has financial interests, arrangements, or affiliations with the manufacturer of products and devices to be discussed in his presentation or who may financially support the educational activity. He has served on speaker boards for Biogen Idec, GE Healthcare, GlaxoSmithKline (Bexxar), and Siemens AG.

Dr. Podoloff has indicated that his presentation will not include discussion of investigational or unlabeled uses of a product.
 
National Comprehensive Cancer Network
The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing education for physicians.

NCCN designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

More Activities from NCCN


Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.